SMTL ID : 9cyb.1 (1 other biounit)

SARS-CoV-2 PLpro in complex with inhibitor WEHI-P1

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.98 Å

Oligo State

monomer

Ligands

1 x 01: [(3R)-1-cyclopentylpiperidin-3-yl](6-methoxynaphthalen-2-yl)methanone

01.1: 13 residues within 4Å: Chain A: L.165, G.166, D.167, R.169, M.211, G.212, S.248, A.249, P.250, P.251, Y.267, Y.276, T.304 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:D.167, A:P.250, A:P.251, A:Y.267, A:Y.267 Hydrogen bonds: A:Y.276 Salt bridges: A:D.167 pi-Cation interactions: A:Y.267

1 x SIN: SUCCINIC ACID(Non-covalent)

SIN.2: 10 residues within 4Å: Chain A: W.109, N.112, N.113, S.114, Y.115, L.165, G.166, G.274, H.275, Y.276 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:N.112 Hydrogen bonds: A:W.109, A:S.114, A:S.114, A:S.114, A:Y.115 Water bridges: A:G.166, A:G.274 Salt bridges: A:H.275

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

M Bader, S. et al., A novel PLpro inhibitor improves outcomes in a pre-clinical model of long COVID. Nat Commun (2025)

Release Date

2025-04-09

Peptides

Papain-like protease: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Papain-like protease

Related Entries With Identical Sequence